Umbhali: William Ramirez
Umhla Wokudalwa: 18 Eyomsintsi 2021
Hlaziya Umhla: 14 Eyenkanga 2024
Anonim
8 Excel tools everyone should be able to use
Ividiyo: 8 Excel tools everyone should be able to use

Umxholo

"Ikofu eluhlaza" ziimbewu zekofu (iimbotyi) zeziqhamo zecoffea ezingekabiwa. Inkqubo yokosa inciphisa izixa zemichiza ebizwa ngokuba yi-chlorogenic acid. Ke ngoko, iimbotyi zekofu eluhlaza zinezinga eliphezulu le-chlorogenic acid xa kuthelekiswa neembotyi zekofu ezigcadiweyo. Chlorogenic acid ikofu eluhlaza kucingelwa ukuba izibonelelo zempilo.

Ikofu eluhlaza iye yathandwa ekunciphiseni ubunzima emva kokuba kukhankanyiwe kumdlalo kaGqirha Oz ngo-2012. Umboniso kaGqirha Oz wabhekisa kuwo njengo "Imbotyi yekofu eluhlaza etshisa amanqatha ngokukhawuleza" kwaye ibanga ukuba akukho mthambo okanye kutya okufunekayo.

Abantu bathatha ikofu eluhlaza yokukhuluphala, isifo seswekile, uxinzelelo lwegazi kunye nezinye iimeko, kodwa abukho ubungqina benzululwazi obuxhasa uninzi lwezi zinto zisetyenziswayo.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe IKHOFI eluhlaza zezi zilandelayo:


Akukho bungqina baneleyo bokulinganisa ukusebenza ...

  • Igazi elonyukayo. Uphando lwakwangoko lubonisa ukuba ukuthatha ikofu eluhlaza ikhupha iiveki ezili-12 ngokuthoba uxinzelelo lwegazi kubantu abadala abanexinzelelo lwegazi.
  • Ukuhlelwa kweempawu ezonyusa umngcipheko wesifo seswekile, isifo sentliziyo, kunye nokubetha (isifo se-metabolic syndrome). Uphando lwakwangoko lubonisa ukuba ukuthatha ikofu eluhlaza kucutha uxinzelelo lwegazi kunye neswekile yegazi ngesixa esincinci kubantu abadala abanesi sifo. Kodwa iswekile yegazi kunye namanqanaba e-cholesterol kunye namanye amafutha awaphuculwanga.
  • Ukutyeba kakhulu. Ukuthatha ikofu eluhlaza yekofu yeeveki eziyi-8 ukuya kwezi-12 kubonakala kunciphisa ubunzima ngesixa esincinci kakhulu kubantu abadala okanye kubantu abadala abatyebe kakhulu.
  • Cholesterol ephezulu.
  • Isifo se-Alzheimer.
  • Seswekile.
  • Ezinye iimeko.
Ubungqina obungakumbi buyafuneka ukukala ikofu eluhlaza kwezi zinto zisetyenziswayo.

Iimbotyi zekofu eziluhlaza ziimbotyi zekofu ezingekabiwa. Ezi mbotyi zekofu ziqulathe isixa esiphezulu se-chlorogenic acid. Le khemikhali kucingelwa ukuba inezibonelelo zempilo. Uxinzelelo lwegazi oluphezulu lunokuchaphazela imithambo yegazi ukuze uxinzelelo lwegazi lunciphiswe.

Ukwehla kobunzima, i-chlorogenic acid ikofu eluhlaza kucingelwa ukuba ichaphazela indlela umzimba ophatha ngayo iswekile yegazi kunye nemetabolism.

Xa kuthathwa ngomlomo: Ikofu eluhlaza yile UKHUSELEKO OLUNOKWENZEKA xa ithathwa ngokufanelekileyo. Izicatshulwa zekhofi eluhlaza ezithathwe kwiidosi ukuya kuthi ga kwi-480 mg yonke imihla zisetyenziswe ngokukhuselekileyo ukuya kuthi ga kwiiveki ze-12. Kwakhona, isicatshulwa esithile sekhofi eluhlaza (uSvetol, uNaturex) sisetyenziswe ngokukhuselekileyo kwiidosi ukuya kuthi ga kwi-200 mg kahlanu mihla le ukuya kuthi ga kwiiveki ezili-12.

Ikofu eluhlaza ine-caffeine. Kukho i-caffeine encinci kakhulu kwikofu eluhlaza kunakwikhofi eqhelekileyo. Kodwa ikofu eluhlaza isenokubangela iziphumo ezinxulumene ne-caffeine efanayo nekofu. Oku kubandakanya ukulala, uvalo nokungazinzi, ukukhathazeka esiswini, isicaphucaphu nokugabha, ukwanda kwentliziyo kunye nokuphefumla, kunye nezinye iziphumo ebezingalindelekanga. Ukutya izixa ezikhulu zekofu kunokubangela nokuba uqaqanjelwe yintloko, uxinzelelo, ukuphazamiseka, ukukhala ezindlebeni, kunye nokubetha kwentliziyo okungaqhelekanga.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: Akukho lwazi lwaneleyo lunokuthenjwa lokwazi ukuba ikofu eluhlaza ikhuselekile ukuba ingasetyenziswa xa ukhulelwe okanye uncancisa. Hlala kwicala elikhuselekileyo kwaye uphephe ukusetyenziswa.

Amanqanaba aphezulu ngokungaqhelekanga e-homocysteine: Ukuthatha idosi ephezulu ye-chlorogenic acid ixesha elifutshane kubangele ukonyuka kwamanqanaba e-plasma homocysteine, anokuhambelana neemeko ezinjengesifo sentliziyo.

Ukuxhalaba: I-caffeine kwikofu eluhlaza inokwenza uxinzelelo lube lubi.

Iingxaki zokopha: Kukho inkxalabo yokuba icaffeine ekwikhofi eluhlaza inokwenza ukuphazamiseka kokopha kube kubi ngakumbi.

Seswekile: Olunye uphando lubonisa ukuba i-caffeine equlethwe kwikofu eluhlaza inokutshintsha indlela abantu abanesifo seswekile abaqhuba ngayo iswekile. I-caffeine ixeliwe ukuba ibangela ukwanda kunye nokuhla kweswekile yegazi. Sebenzisa i-caffeine ngononophelo ukuba unesifo seswekile kwaye ujonge iswekile yegazi lakho ngononophelo.

Urhudo: Ikofu eluhlaza ineecaffeine. I-caffeine esekofini, ngakumbi xa ithathwa ngesixa esikhulu, inokulwenza lubi urhudo.

Isathuthwane: Ikofu eluhlaza ineecaffeine. Abantu abanesathuthwane kufuneka bakuphephe ukusebenzisa icaffeine ngeedosi eziphezulu. Iidosi ezisezantsi zecaffeine kufuneka zisetyenziswe ngononophelo.

IglaucomaUkuthatha i-caffeine equlethwe kwikofu eluhlaza kunokunyusa uxinzelelo ngaphakathi kwiso. Ukonyuka kuqala ngaphakathi kwemizuzu engama-30 kwaye kuhlala ubuncinci imizuzu engama-90.

Igazi elonyukayoUkuthatha i-caffeine efumaneka kwikofu eluhlaza kunokunyusa uxinzelelo lwegazi kubantu abanexinzelelo lwegazi. Nangona kunjalo, oku kunokuba kuncinci kubantu abatya icaffeine evela kwikofu eluhlaza okanye eminye imithombo rhoqo.

Isifo sengqondo sesifo esibuhlungu (IBS): Ikofu eluhlaza ineecaffeine. I-caffeine kwikhofi eluhlaza, ngakumbi xa ithathwa ngobuninzi, inokulwenza lubi ngakumbi urhudo abanye abantu abanalo nge-IBS.

Ukunciphisa amathambo (i-osteoporosis): I-Caffeine evela kwikofu eluhlaza kunye neminye imithombo inokunyusa inani le-calcium egalelwe ngaphandle kumchamo. Oku kunokuwenza buthathaka amathambo. Ukuba une-osteoporosis, nciphisa ukusetyenziswa kwecaffeine ukuya ngaphantsi kwama-300 mg ngosuku. Ukuthatha i-calcium supplements kunokunceda ekwenzeni i-calcium elahlekileyo. Ukuba uphilile ngokubanzi kwaye ufumana ikhalsiyam eyaneleyo ekutyeni okanye kwizongezo zakho, ukuthatha ukuya kwi-400 mg ye-caffeine mihla le (malunga neekomityi ezingama-20 zekofu eluhlaza) akubonakali kwandisa umngcipheko wokufumana i-osteoporosis. Abasetyhini be-Postmenopausal abanesimo esizuze ilifa esibagcina ekusebenziseni i-vitamin D ngokuqhelekileyo, kufuneka balumke ngakumbi xa usebenzisa i-caffeine.

Iphakathi
Lumka ngale nhlanganisela.
Adenosine (Adenocard)
I-caffeine kwikofu eluhlaza inokuthintela iziphumo ze-adenosine (Adenocard). I-Adenosine (Adenocard) ihlala isetyenziswa ngoogqirha ukwenza uvavanyo entliziyweni. Olu vavanyo lubizwa ngokuba luvavanyo loxinzelelo lwentliziyo. Yeka ukutya ikofu eluhlaza okanye ezinye iimveliso ze-caffeine ubuncinci iiyure ezingama-24 ngaphambi kovavanyo loxinzelelo lwentliziyo.
Utywala (i-Ethanol)
Umzimba uyayaphula icaffeine kwikofu eluhlaza ukuyisusa. Utywala bunokunciphisa ukuba umzimba uphula ngokukhawuleza njani ikhafeyini. Ukuthatha ikofu eluhlaza kunye notywala kunokubangela i-caffeine eninzi kwigazi kunye neziphumo ebezingalindelekanga kubandakanya ukothuka, intloko ebuhlungu kunye nokubetha kwentliziyo okukhawulezayo.
Indibaniselwano (Fosamax)
Ikofu eluhlaza inokunciphisa ukuba ingakanani i-alendronate (Fosamax) eyifunxa umzimba. Ukuthatha ikofu eluhlaza kunye ne-alendronate (Fosamax) kwangaxeshanye kunokunciphisa ukusebenza kwe-alendronate (Fosamax). Musa ukuthatha ikofu eluhlaza ngaphakathi kweeyure ezimbini zokuthatha i-alendronate (Fosamax).
IClozapine (iClozaril)
Umzimba uyaphula i-clozapine (Clozaril) ukuze uyilahle. I-caffeine kwikofu eluhlaza inokunciphisa ngokukhawuleza ukuba umzimba uphula njani i-clozapine (Clozaril). Ukuthatha ikofu eluhlaza kunye ne-clozapine (Clozaril) kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga ze-clozapine (Clozaril).
IDipyridamole (iPantantine)
I-caffeine kwikofu eluhlaza inokuthintela iziphumo ze-dipyridamole (Persantine). IDipyridamole (Persantine) ihlala isetyenziswa ngoogqirha ukwenza uvavanyo entliziyweni. Olu vavanyo lubizwa ngokuba luvavanyo loxinzelelo lwentliziyo. Yeka ukuthatha ikofu eluhlaza okanye ezinye iimveliso ze-caffeine ubuncinci iiyure ezingama-24 ngaphambi kovavanyo loxinzelelo lwentliziyo.
Idisulfiram (iAntabuse)
Umzimba uyayaphula icaffeine kwikofu eluhlaza ukuyisusa. I-Disulfiram (i-Antabuse) inokunciphisa ukuba umzimba ulahla njani ngokukhawuleza icaffeine. Ukuthatha ikofu eluhlaza kunye ne-disulfiram (i-Antabuse) kunokunyusa iziphumo kunye neziphumo zekofu eluhlaza kubandakanya ukomelela, ukungakhathali, ukuba nochuku, kunye nabanye.
Ephedrine
Iziyobisi ezikhuthazayo zikhawulezisa inkqubo yeemvakalelo. I-caffeine kwikofu eluhlaza kunye ne-ephedrine zombini iziyobisi ezikhuthazayo. Ukuthatha ikofu eluhlaza kunye ne-ephedrine kunokubangela ukhuthazo kakhulu kwaye ngamanye amaxesha kube neziphumo ebezingalindelekanga ezinzulu kunye neengxaki zentliziyo. Musa ukuthatha iimveliso ezine-caffeine kunye ne-ephedrine ngaxeshanye.
Estrogens
Umzimba uyayaphula icaffeine kwikofu eluhlaza ukuyisusa. I-Estrogens inokunciphisa ngokukhawuleza ukuba umzimba uyaphula njani icaffeine. Ukuthatha iipilisi ze-estrogen kunye nekhofi eluhlaza kunokubangela ukonwaba, intloko ebuhlungu, ukubetha kwentliziyo okukhawulezayo, kunye nezinye iziphumo ebezingalindelekanga.Ukuba uthatha iipilisi ze-estrogen zinciphisa umlinganiselo wakho wecaffeine.

Ezinye iipilisi ze-estrogen zibandakanya i-equine estrogens (Premarin), i-ethinyl estradiol, i-estradiol kunye nezinye.
IFluvoxamine (iLuvox)
Umzimba uyayaphula icaffeine kwikofu eluhlaza ukuyisusa. I-Fluvoxamine (Luvox) inganciphisa ukuba umzimba uphula njani ngokukhawuleza icaffeine. Ukuthatha i-caffeine kunye ne-fluvoxamine (i-Luvox) kunokubangela i-caffeine eninzi emzimbeni, kwaye kwandise iziphumo kunye neempembelelo zecaffeine.
ILithium
Umzimba wakho ngokwemvelo ulahla i-lithium. I-caffeine kwikhofi eluhlaza inokunyusa ukuba umzimba wakho ulahle ngokukhawuleza kangakanani i-lithium. Ukuba uthatha iimveliso eziqukethe i-caffeine kwaye uthatha i-lithium, yeka ukuthatha iimveliso ze-caffeine kancinci. Ukuyeka i-caffeine ngokukhawuleza kunokunyusa iziphumo ebezingalindelekanga ze-lithium.
Amayeza esifuba (i-Beta-adrenergic agonists)
Ikofu eluhlaza ine-caffeine. I-caffeine inokuvuselela intliziyo. Amanye amayeza esifuba anokukhuthaza nentliziyo. Ukuthatha i-caffeine kunye namanye amayeza e-asthma kunokubangela ukuvuselela kakhulu kwaye kubangele iingxaki zentliziyo.

Amanye amayeza e-asthma afaka i-albuterol (Proventil, Ventolin, Volmax), metaproterenol (Alupent), terbutaline (Bricanyl, Brethine), kunye ne-isoproterenol (Isuprel).
Amayeza oxinzelelo (MAOIs)
I-caffeine kwikofu eluhlaza inokuvuselela umzimba. Amanye amayeza asetyenziselwa uxinzelelo anokuvuselela umzimba. Ukuthatha ikofu eluhlaza kunye nokusela amayeza kuxinzelelo kunokubangela ukhuthazo oluninzi kunye neziphumo ebezingalindelekanga ezinzulu kubandakanya ukubetha kwentliziyo okukhawulezileyo, uxinzelelo lwegazi, uvalo kunye nabanye.

Olunye lala mayeza asetyenziselwa uxinzelelo lubandakanya i-phenelzine (Nardil), tranylcypromine (Parnate), kunye nezinye.
Amayeza acothisa ukujiya kwegazi (iAnticoagulant / iziyobisi zeAntiplatelet)
I-caffeine kwikhofi eluhlaza inokunciphisa ukucima kwegazi. Ukuthatha ikofu eluhlaza kunye namayeza acothisa ukujiya kunokunyusa amathuba okugruzuka nokopha.

Amanye amayeza acothisa ukucoca igazi aquka iasprini, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, abanye), ibuprofen (Advil, Motrin, abanye), naproxen (Anaprox, Naprosyn, abanye), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), kunye nezinye.
Inikotini
Ukuthatha icaffeine kwikofu eluhlaza kunye nenicotine kunokunyusa izinga lokukhawuleza kwentliziyo kunye noxinzelelo lwegazi.
IPentobarbital (iNembutal)
Iziphumo ezikhuthazayo zecaffeine kwikofu eluhlaza zinokuthintela ukuvelisa ukulala kwepentobarbital.
IPhenylpropanolamine
I-caffeine kwikofu eluhlaza inokuvuselela umzimba. I-Phenylpropanolamine inokuvuselela umzimba. Ukuthatha icaffeine kunye ne-phenylpropanolamine kunye kunokubangela ukonyusa kakhulu kunye nokunyusa ukubetha kwentliziyo, uxinzelelo lwegazi, kunye nokubangela uloyiko.
Riluzole (Rilutek)
Umzimba uqhekeza i-riluzole (iRilutek) ukuyikhupha. Ukuthatha ikofu eluhlaza kunganciphisa ukuba umzimba uphula njani i-riluzole (Rilutek) ngokukhawuleza. Kwiingcamango, ukusetyenziswa okudibeneyo kunokunyusa imiphumo kunye nemiphumo emibi ye-riluzole.
Iziyobisi ezikhuthazayo
Iziyobisi ezikhuthazayo zikhawulezisa inkqubo yeemvakalelo. Ngokukhawulezisa inkqubo ye-nervous, amayeza avuselelayo anokukwenza uzive ujitter kwaye ukhawulezise ukubetha kwentliziyo yakho. I-caffeine kwikofu eluhlaza inokukhawulezisa inkqubo yeemvakalelo. Ukuthatha ikofu eluhlaza kunye neziyobisi ezikhuthazayo kunokubangela iingxaki ezinje ngokunyuka kwenqanaba lentliziyo kunye noxinzelelo lwegazi. Gwema ukuthatha iziyobisi ezikhuthazayo kunye nekhofi eluhlaza.

Ezinye iziyobisi ezikhuthazayo zibandakanya i-diethylpropion (Tenuate), epinephrine, phentermine (Ionamin), pseudoephedrine (Sudafed), kunye nezinye ezininzi.
Ithiophylline
I-caffeine kwikofu eluhlaza isebenza ngokufanayo kwi-theophylline. I-caffeine inokunciphisa ngokukhawuleza ukuba umzimba ulahla njani i-theophylline. Ukuthatha ikofu eluhlaza kunye nokuthatha i-theophylline kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga ze-theophylline.
Verapamil (Calan, abanye)
Umzimba uyayaphula icaffeine kwikofu eluhlaza ukuyisusa. I-Verapamil inokunciphisa ukuba umzimba ulahla njani ngokukhawuleza icaffeine. Ukusela ikofu kunye nokuthatha i-verapamil kunokunyusa umngcipheko weziphumo ebezingalindelekanga kwikofu eluhlaza kubandakanya ukungcangcazela, intloko ebuhlungu kunye nentliziyo eyandayo.
Incinci
Jonga olu dibaniso.
Iintsholongwane (iquinolone antibiotics)
Umzimba uqhekeza icaffeine kwikofu eluhlaza ukuyisusa. Amanye amachiza anokunciphisa ngokukhawuleza ukuba umzimba uyaphula icaffeine. Ukuthatha la machiza kunye nekofu eluhlaza kunokunyusa umngcipheko weziphumo ebezingalindelekanga kubandakanya ukonwaba, intloko ebuhlungu, ukubetha kwentliziyo, kunye nabanye.

Amanye amayeza okubulala iintsholongwane anciphisa ukukhawuleza kwe-caffeine kubandakanya i-ciprofloxacin (Cipro), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), kunye nezinye.
Iipilisi zolawulo lokuzalwa (iziyobisi zokuthintela ukukhulelwa)
Umzimba uyayaphula icaffeine kwikofu eluhlaza ukuyisusa. Iipilisi zolawulo lokuzalwa zinganciphisa ukuba umzimba uphula kanjani ngokukhawuleza icaffeine. Ukuthatha ikofu eluhlaza kunye neepilisi zokulawula ukuzalwa kunokubangela ukonwaba, intloko ebuhlungu, ukubetha kwentliziyo okukhawulezayo, kunye nezinye iziphumo ebezingalindelekanga.

Ezinye iipilisi zolawulo lokuzalwa zibandakanya i-ethinyl estradiol kunye ne-levonorgestrel (Triphasil), i-ethinyl estradiol kunye ne-norethindrone (i-Ortho-Novum 1/35, i-Ortho-Novum 7/7/7), kunye nezinye.
ICimetidine (iTagamet)
Umzimba uyayaphula icaffeine kwikofu eluhlaza ukuyisusa. I-Cimetidine (iTagamet) inokunciphisa ukuba umzimba wakho uyaphula ngokukhawuleza njani icaffeine. Ukuthatha i-cimetidine (iTagamet) kunye nekhofi eluhlaza kunokunyusa amathuba okuba neziphumo ebezingalindelekanga kubandakanya ukomelela, intloko ebuhlungu, ukubetha kwentliziyo okukhawulezileyo, kunye nabanye.
IFluconazole (iDiflucan)
Umzimba uyayaphula icaffeine kwikofu eluhlaza ukuyisusa. IFluconazole (Diflucan) inokunciphisa ukuba umzimba uyilahla ngokukhawuleza kangakanani icaffeine. Ukuthatha i-fluconazole (iDiflucan) kunye nekhofi eluhlaza kunokunyusa iziphumo kunye neziphumo zekofu kubandakanya uloyiko, ixhala kunye nokuqaqanjelwa sisisu.
Amayeza eswekile (iziyobisi zeAntidiabetes)
I-caffeine kwikofu eluhlaza inokunyusa iswekile yegazi. Amayeza eswekile asetyenziselwa ukunciphisa iswekile yegazi. Ngokwandisa iswekile yegazi, ikofu eluhlaza inokunciphisa ukusebenza kwamayeza eswekile. Jonga eswekile yegazi lakho ngokusondeleyo. Umthamo weyeza lakho leswekile unokufuna ukuba utshintshwe.

Amanye amayeza asetyenziselwa isifo seswekile aquka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbutamide (i-Orinase), .
Amayeza oxinzelelo lwegazi oluphezulu (iziyobisi ezichasayo)
Ikofu eluhlaza inokunciphisa uxinzelelo lwegazi. Ukuthatha ikofu eluhlaza kunye namayeza oxinzelelo lwegazi kunokubangela ukuba uxinzelelo lwegazi luye phantsi kakhulu.

Amanye amayeza oxinzelelo lwegazi aphezulu abandakanya i-captopril (Capoten), enalapril (Vasotec), losartan (Cozaar), valsartan (Diovan), diltiazem (Cardizem), Amlodipine (Norvasc), hydrochlorothiazide (HydroDIURIL), furosemide (Lasix), kunye nabanye abaninzi. .
Mexiletine (Mexitil)
Ikofu eluhlaza ine-caffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. I-Mexiletine (Mexitil) inokunciphisa ngokukhawuleza ukuba umzimba uyaphula njani icaffeine. Ukuthatha i-Mexiletine (Mexitil) kunye nekofu eluhlaza kunokunyusa iziphumo ezinxulumene ne-caffeine yekofu eluhlaza.
I-Terbinafine (iLamisil)
Umzimba uyayaphula icaffeine kwikofu eluhlaza ukuyisusa. I-Terbinafine (i-Lamisil) inganciphisa ukuba umzimba ulahla njani ikhafeyini ngokukhawuleza kwaye inyuse umngcipheko weziphumo ebezingalindelekanga kubandakanya ukothuka, intloko ebuhlungu, ukubetha kwentliziyo kunye nezinye iziphumo.
Ikrakra iorenji
Ukukrakra kwe-orenji ngokudibeneyo ne-caffeine okanye i-caffeine ene-herbs inokunyusa uxinzelelo lwegazi kunye nenqanaba lentliziyo kubantu abadala abasempilweni abanexinzelelo lwegazi eliqhelekileyo. Oku kunokunyusa umngcipheko wokuba neengxaki ezinzulu zentliziyo. Kulumkele ukudibanisa.
Imifuno eneCaffeine kunye nezongezo
Sebenzisa ikofu eluhlaza kunye namanye amayeza ane-caffeine kunye nezongezo zonyusa ukubonakaliswa kwe-caffeine kwaye zonyusa umngcipheko wokuphucula iziphumo ezinxulumene ne-caffeine. Amanye amayeza endalo ane-caffeine aquka iti emnyama, i-cocoa, i-cola nut, iti eluhlaza, iti ye-oolong, i-guarana kunye neqabane.
Ikhalsiyam
Ukutya okuphezulu kwe-caffeine ekutyeni nasekuseleni kubandakanya ikofu eluhlaza kuyandisa inani le-calcium elichithwe ngaphandle kumchamo.
ICyclodextrin
Ifayibha yokutya i-cyclodextrin ibonakalisiwe ukuba inezinto ezithile zekhofi eluhlaza enoxanduva lokunciphisa uxinzelelo lwegazi. Ngokwethiyori, ukusebenzisa icyclodextrin kunye nekofu eluhlaza kunokunciphisa ukufakwa kweli candelo kunye nokunciphisa iziphumo eziluncedo kuxinzelelo lwegazi.
Ephedra (Ma huang)
Ikofu eluhlaza ine-caffeine, ekhuthazayo. Sebenzisa ikofu eluhlaza ene-ephedra, ekwakhuthazayo, inokunyusa umngcipheko wokufumana iziphumo ezibi okanye ezisongela ubomi ezinje ngoxinzelelo lwegazi, isifo sentliziyo, ukubetha kwentliziyo, ukuxhuzula kunye nokufa. Kuphephe ukuthatha ikofu kunye ephedra kunye nezinye ivuselela.
Iherbs kunye nezongezo ezinokunciphisa uxinzelelo lwegazi
Ikofu eluhlaza iyanciphisa uxinzelelo lwegazi. Xa isetyenziswa namanye amayeza kunye nezongezo ezinciphisa uxinzelelo lwegazi, ikofu eluhlaza inokuba neziphumo zokwehlisa uxinzelelo lwegazi. Amanye amayeza endalo anexinzelelo lwegazi-ukunciphisa iziphumo kubandakanya i-alpha-linolenic acid, i-blond psyllium, i-calcium, i-cocoa, i-cod yeoyile yesibindi, i-coenzyme Q-10, igalikhi, iminquma, i-potassium, i-pycnogenol, i-orenji eswiti, ivithamin C, ingqolowa yengqolowa kunye nezinye .
Iherbs kunye nezongezo ezinokunciphisa iswekile yegazi
Ukukhutshwa kwekhofi eluhlaza kunokunciphisa amanqanaba eglucose egazini. Ukuyisebenzisa ngamanye amayeza okanye izongezo ezinefuthe elifanayo kunokubangela amanqanaba eswekile yegazi ukuba awe phantsi kakhulu. Amanye amayeza kunye nezongezo ezinokuhlisa iswekile yegazi zibandakanya i-alpha-lipoic acid, i-chromium, i-devil's claw, i-fenugreek, igalikhi, i-guar gum, i-chestnut yehashe, i-Panax ginseng, i-psyllium, i-ginseng yaseSiberia, nezinye.
Iherbs kunye nezongezo ezinokucothisa igazi
I-caffeine kwikhofi eluhlaza inokunciphisa ukucima kwegazi. Ukuthatha ikofu eluhlaza kunye nokusebenzisa imifuno enokuthi icothise nokujiya kwegazi kunokonyusa umngcipheko wokopha kwabanye abantu. Amanye ala mayeza abandakanya i-angelica, i-clove, i-danshen, igalikhi, ijinja, iginkgo, iPanax ginseng, kunye nezinye.
Intsimbi
Izinto ezithile zekofu eluhlaza zinokuthintela i-iron ekufunxweni ekutyeni. Ngokwethiyori, oku kungakhokelela kumanqanaba entsimbi emzimbeni ukuba ube sezantsi kakhulu.
Magnesium
Ukuthatha isixa esikhulu sekhofi eluhlaza kunokunyusa inani lemagniziyam ekhutshelwe ngaphandle kumchamo.
IMelatonin
Ukuthatha i-caffeine kunye ne-melatonin kunye kunokunyusa amanqanaba e-melatonin.
Akukho kunxibelelana kwaziwayo nokutya.
Idosi efanelekileyo yekofu eluhlaza ixhomekeke kwizinto ezininzi ezinje ngeminyaka yomsebenzisi, impilo, kunye nezinye iimeko. Ngeli xesha akukho lwazi lwaneleyo lwesayensi ukumisela uluhlu olufanelekileyo lweedosi zekofu eluhlaza (ebantwaneni / kubantu abadala). Gcina ukhumbula ukuba iimveliso zendalo azisoloko zikhuselekile kwaye iidosi zibalulekile. Qiniseka ukuba ulandela umkhombandlela ofanelekileyo kwiilebheli zemveliso kwaye uqhagamshelane nosokhemesti okanye ugqirha okanye olunye uqeqesho kwezempilo ngaphambi kokusebenzisa.

Arabica Green Coffee Beans, Café Marchand, Café Verde, Café Vert, Coffea arabica, Coffea arnoldiana, Coffea bukobensis, Coffea canephora, Coffea liberica, Coffea robusta, Extrait de Café Vert, Extrait de Fève de Café Vert, Iivenkile de Café Vert Arabica, Fèves de Café Vert Robusta, GCBE, GCE, Green Coffee Beans, Green Coffee Bean Extract, Green Coffee Extract, Green Coffee Powder, Poudre de Café Vert, Raw Coffee, Raw Coffee Extract, Robusta Green Coffee Iimbotyi, Svetol .

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.


  1. URoshan H, Nikpayam O, Sedaghat M, Sohrab G.Iziphumo zekofu eluhlaza yokukhupha ukongezwa kwi-indices ye-anthropometric, ulawulo lwe-glycemic, uxinzelelo lwegazi, iprofayili ye-lipid, ukumelana ne-insulin kunye nokutya kwizigulana ezine-metabolic syndrome: ulingo lwezonyango olungenamsebenzi. Br J Isondlo. Ngo-2018; 119: 250-258. Jonga i-abstract.
  2. UChen H, uHuang W, uHuang X, et al. Iziphumo zokutsalwa kwembotyi yekofu eluhlaza kumanqanaba eeproteni asebenzayo: Ukuphononongwa ngokuchanekileyo kunye nokuhlaziywa kwemeta kwezilingo ezilawulwa ngokungahleliwe. Gcwalisa iTher Med. Ngo-2020; 52: 102498. Jonga i-abstract.
  3. I-Twaruzek M, iKosicki R, Kwiatkowska-Gizynska J, Grajewski J, Altyn I. I-Ochratoxin A kunye ne-citrinin kwikofu eluhlaza kunye nezongezo zokutya ezikhutshiweyo zekofu eluhlaza. Ityhefu. Ngo-2020; 188: 172-177. Jonga i-abstract.
  4. UNikpayam O, uNajafi M, uGhaffari S, uJafarabadi MA, uSohrab G, uRoshanravan N.Iziphumo zokukhupha ikofu eluhlaza kwiglass yegazi, uxinzelelo lwe-insulin kunye novavanyo lweemodeli zasekhaya zokunganyangeki kwe-insulin (HOMA-IR): uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta yezifundo zongenelelo. Iswekile yeMetab Syndr. 2019; 11: 91. Jonga i-abstract.
  5. UMartínez-López S, uSarriá B, uMateos R, uBravo-Clemente L. Ukusetyenziswa okuphakathi kwekhofi eluhlaza / eyosiweyo etyebileyo kwi-caffeoylquinic acid inciphisa ukumakisha kwentliziyo: iziphumo ezivela kwizifundo ezingahleliwe, ezinqamlezileyo, ezilawulwayo kwizifundo ezisempilweni kunye ne-hypercholesterolemic . I-Eur J Isondlo. Ngo-2019; 58: 865-878. Jonga i-abstract.
  6. UAsbaghi ​​O, uSadeghian M, uRahmani S, et al. Iziphumo zekofu eluhlaza yokukhupha ukongezwa kumanyathelo e-anthropometric kubantu abadala: Uhlalutyo olucwangcisiweyo olucwangcisiweyo kunye novavanyo lokuphendula ngemeta yovavanyo lwezilingo zeklinikhi. Gcwalisa iTher Med. Ngo-2020; 51: 102424. Jonga i-abstract.
  7. I-Cozma-Petrut A, i-Loghin F, i-Miere D, i-Dumitrascu kunye ne-DL. Ukutya kwisifo esinganyangekiyo samathumbu: Yintoni onokuyincoma, hayi into eyalela izigulane! Kwihlabathi J Gastroenterol. Ngo-2017; 23: 3771-3783. Jonga i-abstract.
  8. IRao SS. Unyango lwangoku kunye nolukhulayo kunyango lokungabinako ukungasebenzi. J Klinikhi yeGastroenterol. Ngo-2014; 48: 752-64. Jonga i-abstract.
  9. Wikoff D, Welsh BT, Henderson R, et al. Ukuphononongwa ngokuchanekileyo kweziphumo ezinokubakho zokusetyenziswa kwe-caffeine kubantu abadala abasempilweni, abasetyhini abakhulelweyo, abakwishumi elivisayo kunye nabantwana. Ukutya iChem Toxicol 2017; 109: 585-648. Jonga i-abstract.
  10. UCappelletti S, uPiacentino D, uFineschi V, uFrati P, uCipollini L, uAromatario M. Ukufa okunxulumene neCaffeine: indlela yokufa kunye neendidi zomngcipheko. Izondlo. 2018 ngoMeyi 14; 10. pii: E611. Jonga i-abstract.
  11. UMagdalan J, uZawadzki M, uSkowronek R, et al. Ukunxila okungafakwanga nokuzalwa kunye ne-caffeine emsulwa-ingxelo yamatyala amathathu ahlukeneyo. I-Forensic Sci Med Pathol. Ngo-2017 Sep; 13: 355-58. Jonga i-abstract.
  12. I-Tejani FH, i-Thompson RC, i-Kristy R, i-Bukofzer S.Iziphumo zecaffeine kwi-SPECT myocardial perfusion imaging ngexesha le-regadenoson pharmacologic yoxinzelelo: isifundo esinokwenzeka, esingenamkhethe kunye nesininzi. I-Int J yokuCinga ngeCardiovasc. NgoJuni ka-2014; 30: 979-89. ikhonkco: 10.1007 / s10554-014-0419-7. Epub 2014 17. Jonga i-abstract.
  13. UPoussel M, uKimmoun A, uLevy B, uGambier N, uDudek F, uPuskarczyk E, uPoussel JF, uChenuel B. Isifo sentliziyo esibulalayo kulandela ukuzithoba kwe-caffeine kwi-athlete eyakha umzimba. Int J Cardiol. Ngo-2013 1; 166: e41-2. ikhonkco: 10.1016 / j.ijcard.2013.01.238. Epub 2013 7. Akukho nto ikhoyo inokubakho. Jonga i-abstract.
  14. IJabbar SB, uHanly MG. I-caffeine overdose ebulalayo: ingxelo yamatyala kunye nokuphononongwa koncwadi. NdinguJ J Forensic Med Pathol. Ngo-2013; 34: 321-4. ikhonkco: 10.1097 / PAF.0000000000000058. Uphononongo. Jonga i-abstract.
  15. Bonsignore A, Sblano S, Pozzi F, Ventura F, Dell'Erba A, Palmiere C. Ityala lokuzibulala ngokungenisa icaffeine. I-Forensic Sci Med Pathol. Ngo-2014 Sep; 10: 448-51. ikhonkco: 10.1007 / s12024-014-9571-6. Epub 2014 27. Jonga i-abstract.
  16. I-Beaudoin MS, uAllen B, uMazzetti G, uSullivan PJ, noGraham TE. Ukungenisa i-caffeine kuthintela ubuntununtunu be-insulin ngendlela exhomekeke kwidosi kokubini kwabasetyhini nabasetyhini. Iappl yePhysol yeNutab yeMetab. Ngo-2013; 38: 140-7. ikhonkco: 10.1139 / apnm-2012-0201. Epub 2012 9. Jonga into engaqondakaliyo.
  17. Ipakethe yolwazi lweSvetol. INaturex, iAvignon, eFrance. Ngomhla ka-Matshi 2013. Iyafumaneka apha: http://greencoffee.gr/wp-content/uploads/2013/12/GA501071_PRODUCT-INFO-PACK_04-06-2013.pdf (ifumaneka ngoJulayi 6, 2015).
  18. UVinson J, uBurnham B.Ukurhoxiswa: Ukungahleliwe, ukungaboni kakuhle, ukulawulwa kwe-placebo, idosi yomgama, isifundo se-crossover ukuvavanya ukusebenza kunye nokhuseleko lokukhutshwa kwembotyi yekofu eluhlaza kwizifundo ezingaphezulu komzimba. Isifo seswekile iMetab Syndr Obes 2014; 7: 467. Iyafumaneka kwi: www.ncbi.nlm.nih.gov/pmc/articles/PMC4206203/.
  19. Ukukhutshwa kweKhomishini yoRhwebo yeFederal. Umvelisi wembotyi yekofu eluhlaza uhlawula iindleko ze-FTC zokutyhala imveliso yazo ngokusekwe kwiziphumo zesifundo "esineempazamo" zokunciphisa umzimba. Ifumaneka apha: www.ftc.gov/news-events/press-releases/2014/09/green-coffee-bean-manufacturer-settles-ftc-charges-pushing-its (ifikeleleke ngoJulayi 5, 2015).
  20. I-Saito, T., Tsuchida, T., Watanabe, T., Arai, Y., Mitsui, Y., Okawa, W., kunye neKajihara, Y. Iziphumo zebhontshisi yekofu ekukhupheni uxinzelelo lwegazi. IJpn J Med Pharm Sci 2002; 47: 67-74.
  21. IBlum, J., Lemaire, B., kunye neLafay, S. Iziphumo zokukhupha ikofu eluhlaza eluhlaza ekhutshwe kwi-glycaemia: isifundo somqhubi esilindelweyo. IiNutrafoods 2007; 6: 13-17.
  22. UDellalibera, O., uLemaire, B., kunye noLafay, S. Svetol®, ukukhutshwa kwekofu eluhlaza, kunciphisa ukutyeba kwaye kwonyusa ukutyeba kumyinge wobunzima bamafutha kumavolontiya anengxaki yokutyeba. IPytotherapie 2006; 4: 1-4.
  23. UArion, WJ, Canfield, WK, Ramos, FC, Schindler, PW, Burger, HJ, Hemmerle, H., Schubert, G., Ngezantsi, P., kunye noHerling, iAW Chlorogenic acid kunye nehydroxynitrobenzaldehyde: inhibitors ezintsha zeswekile yesibindi 6 -phosphatase. IArch. Ibhayoloji. 3-15-1997; 339: 315-322. Jonga i-abstract.
  24. I-Peyresblanques, J. [Ukudibana kokudibana nekofu eluhlaza]. Inkunzi yenkomo.Soc.Ophtalmol. Ngo-1984; 84: 1097-1098. Jonga i-abstract.
  25. UFranzke, C., Grunert, K. S., Hildebrandt, U., noGriehl, H. [Kumxholo we-theobromine kunye ne-theophylline yekofu eluhlaza kunye neti]. Ikhemisi 9-9-1968; 23: 502-503. Jonga i-abstract.
  26. UZuskin, E., Kanceljak, B., Skuric, Z., kunye noButkovic, D. Ukuphinda kusebenze kwakhona kweBronchial ekuvezeni ikofu eluhlaza. UBr. J. Ind. Ngowe-1985; 42: 415-420. Jonga i-abstract.
  27. Uragoda, C. G. Iimpawu ezibukhali kubasebenzi bekofu. I-J.Trop.Med.Hyg. Ngo-1988; 91: 169-172. Jonga i-abstract.
  28. USuzuki, A., Fujii, A., Jokura, H., Tokimitsu, I., Hase, T., kunye noSaito, I. I-Hydroxyhydroquinone iphazamisa ukubuyiselwa kwe-asidi ye-chlorogenic eyenziweyo ye-endothelial function kwi-rats ngokuzenzekelayo. Ndingu. J. Hypertens. Ngo-2008; 21: 23-27. Jonga i-abstract.
  29. USelmar, D., Bytof, G., noKnopp, S. E. Ukugcinwa kwekhofi eluhlaza (Coffea arabica): ukwehla kokusebenza kunye notshintsho lwee-precursors ezinokubakho. UAnn. Ngo-2008; 101: 31-38. Jonga i-abstract.
  30. Oka K. Yakugaku Zasshi 2007; 127: 1825-1836. Jonga i-abstract.
  31. UTakahama, U., Ryu, K., kunye noHirota, S.I-asidi yeChlorogenic kwikofu inokuthintela ukwenziwa kwe-dinitrogen trioxide ngokukhangela i-nitrogen dioxide eyenziwe kwindawo yomlomo womntu. Ukutya Chem. 10-31-2007; 55: 9251-9258. Jonga i-abstract.
  32. I-Monteiro, M., Farah, A., Perrone, D., Trugo, L. C., kunye noDonangelo, C. Iichlorogenic acid iikhompawundi ezivela kwikofu ziyaxutywa ngokwahlukileyo kwaye zidibanise abantu. UJutut. Ngo-2007; 137: 2196-2201. Jonga i-abstract.
  33. UGlei, M., Kirmse, A., Habermann, N., Persin, C., kunye nePhuli-Zobel, B. L. Isonka esityetyiswe ngokukhutshwa kwekofu eluhlaza sinemisebenzi ye-chemoprotective kunye ne-antigenotoxic kwiiseli zabantu. Isondlo Umhlaza 2006; 56: 182-192. Jonga i-abstract.
  34. IGreenberg, J. A., Boozer, C.N, kunye noGeliebter, A. Ikofu, isifo seswekile, kunye nolawulo lobunzima. NdinguJ. Clin. Ngo-2006; 84: 682-693. Jonga i-abstract.
  35. USuzuki, A., Fujii, A., Yamamoto, N., Yamamoto, M., Ohminami, H., Kameyama, A., Shibuya, Y., Nishizawa, Y., Tokimitsu, I., kunye noSaito, I. Ukuphuculwa koxinzelelo lwexinzelelo kunye nokungasebenzi kakuhle kwemithambo yegazi ngekhofi engenasifo i-hydroxyhydroquinone kwimodeli yemvelo yoxinzelelo lwegazi. IIFEBHU Lett. 4-17-2006; 580: 2317-2322. Jonga i-abstract.
  36. UHigdon, J. V. kunye noFrei, B. Ikofu kunye nempilo: uphononongo lophando lomntu lwamva nje. Ukugxeka uMfu. Ukutya Sci. Ngo-2006; 46: 101-123. Jonga i-abstract.
  37. Glauser, T., Bircher, A., kunye noWuthrich, B. [Isilumkiso somkhuhlane esibangelwa luthuli lweembotyi zekofu eluhlaza]. I-Schweiz, iMed. IWochenschr. 8-29-1992; 122: 1279-1281. Jonga i-abstract.
  38. UGonthier, M. P., Verny, M. A., Besson, C., Remesy, C., kunye noScalbert, A. I-Chlorogenic acid bioavailability ubukhulu becala ixhomekeke kwimetabolism yayo yi-gut microflora kwiigundane. UJutut. 2003; 133: 1853-1859. Jonga i-abstract.
  39. U-Olthof, M. R., Hollman, P. C., Buijsman, M. N., van Amelsvoort, J. M., kunye noKatan, M. B. Chlorogenic acid, quercetin-3-rutinoside kunye neeti ezimnyama zephenol zixutywe kakhulu ebantwini. UJutut. 2003; 133: 1806-1814. Jonga i-abstract.
  40. UMoridani, M. Y., Scobie, H., kunye no-O'Brien, P. J. Metabolism ye-caffeic acid ngamagciwane e-hepatocytes kunye namaqhezu eeselfowuni. Ityhefu. 7-21-2002; 133 (2-3): 141-151. Jonga i-abstract.
  41. UDaglia, M., Tarsi, R., Papetti, A., Grisoli, P., Dacarro, C., Pruzzo, C., noGazzani, G. Isiphumo sokudibanisa ikofu eluhlaza kunye eyosiweyo kwiipropathi zokuncamathela kweStreptococcus mutans -i-hydroxyapatite edibeneyo. Ukutya Chem. 2-27-2002; 50: 1225-1229. Jonga i-abstract.
  42. URichelle, M., Tavazzi, I., kunye no-Offord, E. Ukuthelekiswa kwemisebenzi yokulwa ne-antioxidant yeziyobisi ezisetyenziswa rhoqo (ikofu, icocoa, kunye neti) ezilungiselelwe ikomityi nganye. Ukutya Chem. 2001; 49: 3438-3442. Jonga i-abstract.
  43. ICouteau, D., McCartney, A. L., Gibson, G. R., Williamson, G., kunye neFaulds, C. B. Ukuzahlula kunye nokubonakaliswa kweebhaktiriya zabantu ze-colonic ezikwaziyo ukwenza i-hydrolyse chlorogenic acid. IMicrobiol. 2001; 90: 873-881. Jonga i-abstract.
  44. UDaglia, M., Papetti, A., Gregotti, C., Berte, F., kunye noGazzani, G. In vitro antioxidant kunye ne-ex vivo imisebenzi yokukhusela ikofu eluhlaza kunye eyosiweyo. Ukutya Chem. Ngo-2000; 48: 1449-1454. Jonga i-abstract.
  45. UHerling, A. W., Burger, H., Schubert, G., Hemmerle, H., Schaefer, H., kunye noKramer, W.Ukutshintshwa kwe-carbohydrate kunye ne-lipid intermediary metabolism ngexesha lokuthintela i-glucose-6-phosphatase kwiigundane. I-EJ. IPharmacol. 12-10-1999; 386: 75-82. Jonga i-abstract.
  46. IBassoli, BK, Cassolla, P., Borba-Murad, GR, Constantin, J., Salgueiro-Pagadigorria, CL, Bazotte, RB, da Silva, RS, kunye no-Souza, HM Chlorogenic acid inciphisa incopho yeglucose yomlomo Uvavanyo lokunyamezelwa kweswekile: Iziphumo zokukhutshwa kwe-hepatic glucose kunye ne-glycaemia. Iseli yeBhayoloji. Ngo-2008; 26: 320-328. Jonga i-abstract.
  47. UAlmeida, A. A., Farah, A., Silva, D. A., Nunan, E. A., noGloria, M. B. Umsebenzi we-Antibacterial wezicatshulwa zekofu kunye nezinto ezikhethiweyo zekhemikhali zekofu ezichasene ne-enterobacteria. J Agric. Ukutya Chem 11-15-2006; 54: 8738-8743. Jonga i-abstract.
  48. UDimaio, V.J kunye noGarriott, J. C. Lethal ityhefu yetyhefu yomntwana. Inzululwazi yophando. Ngowe-1974; 3: 275-278. Jonga i-abstract.
  49. UAlstott, R. L., Miller, A. J., kunye noForney, R. B. Ingxelo yokufa kwabantu ngenxa yecaffeine. Isayensi yezomthetho. Ngo-1973; 18: 135-137. Jonga i-abstract.
  50. Orozco-Gregorio, H., Mota-Rojas, D., Bonilla-Jaime, H., Trujillo-Ortega, ME, Becerril-Herrera, M., Hernandez-Gonzalez, R., kunye noVillanueva-Garcia, D. Iziphumo ze ukulawulwa kwecaffeine kwizinto eziguqulweyo zehagu zeentsana ezineepheripartum asphyxia. Ndingu. J Vet. Res. Ngo-2010; 71: 1214-1219. Jonga i-abstract.
  51. I-Thelander, G., Jonsson, A. K., Personne, M., Forsberg, G. S., Lundqvist, K. M., and Ahlner, J. Caffeine fatalities- ngaba ukuthengisa kuthintela ukuthintela ukunxila? Kwiklinikhi yetyhefu. (Phila) 2010; 48: 354-358. Jonga i-abstract.
  52. I-Buscemi, S., i-Verga, i-S, i-Batsis, i-JA, i-Donatelli, i-M, i-Tranchina, i-MR, i-Belmonte, i-S, i-Mattina, i-A, i-Re, i-A, ne-Cerasola, i-G. kwizifundo ezisempilweni. I-Eur. J yeNyango yeZonyango. Ngo-2010; 64: 483-489. Jonga i-abstract.
  53. URudolph, T. kunye noKnudsen, K. Ityala letyhefu yecaffeine. Acta Anaesthesiol.Scand 2010; 54: 521-523. Jonga i-abstract.
  54. UMoisey, uL. L., uRobinson, u-E, no-Graham, u-T. Ukusetyenziswa kwekofu ene-caffeine kunye nokutya okuphezulu kwe-carbohydrate kuchaphazela imetabolism yasemva kwexesha yokuvavanywa kweswekile yomlomo kulutsha olusempilweni. Br. J Isondlo. Ngo-2010; 103: 833-841. Jonga i-abstract.
  55. IMacKenzie, T., Comi, R., Sluss, P., Keisari, R., Manwar, S., Kim, J., Larson, R., kunye noBaron, JA Iziphumo zeMetabolic kunye nehomoni yecaffeine: ilingo le-crossover elilawulwa yimfama. Imetabolism 2007; 56: 1694-1698. Jonga i-abstract.
  56. van Dam, R. M. Ikofu kunye nohlobo lwe-2 yeswekile: ukusuka kwiimbotyi ukuya kwiiseli ze-beta. Isondlo Metab Cardiovasc. Ngo-2006; 16: 69-77. Jonga i-abstract.
  57. I-Smits, P., Temme, L., kunye no-Thien, T.Ukuhlangana kwentliziyo phakathi kwe-caffeine kunye ne-nicotine ebantwini. KwiKlinikhi ye-Pharmacol Ther 1993; 54: 194-204. Jonga i-abstract.
  58. U-Liu, u-T. Kunye no-Liau, uJ. I-Caffeine yonyusa ubume bempendulo ye-BOLD ebonakalayo. Imvelaphi. 2-1-2010; 49: 2311-2317. Jonga i-abstract.
  59. Ursing, C., Wikner, J., Brismar, K., kunye noRojdmark, S. Caffeine iphakamisa inqanaba le-serum melatonin kwizifundo ezisempilweni: uphawu lwe-melatonin metabolism yi-cytochrome P450 (CYP) 1A2. J. Endocrinol. Utyalomali 2003; 26: 403-406. Jonga i-abstract.
  60. IHartter, S., Nordmark, A., Rose, D. M., Bertilsson, L., Tybring, G., kunye noLaine, K. Iziphumo zokutya kwe-caffeine kwi-pharmacokinetics ye-melatonin, iyeza lokuphanda lomsebenzi we-CYP1A2. Br. J. Clin, iPharmacol. 2003; 56: 679-682. Jonga i-abstract.
  61. Gasior, M., Swiader, M., Przybylko, M., Borowicz, K., Turski, WA, Kleinrok, Z., kunye noCzuczwar, SJ Felbamate ibonisa ukuthambeka okuphantsi kokunxibelelana ne-methylxanthines kunye ne-Ca2 + iimodyuli zesiteshi ngokuchasene nokuvavanywa kovavanyo kwiimpuku. . I-Eur. J Pharmacol 7-10-1998; 352 (2-3): 207-214. Jonga i-abstract.
  62. UVaz, J., Kulkarni, C., David, J., noJoseph, T. Impembelelo ye-caffeine kwiprofayili ye-pharmacokinetic ye-sodium valproate kunye ne-carbamazepine kumavolontiya aqhelekileyo abantu. Indiya J.Exp. Ibhayol. Ngo-1998; 36: 112-114. Jonga i-abstract.
  63. IChroscinska-Krawczyk, M., Jargiello-Baszak, M., Walek, M., Tylus, B., kunye noCzuczwar, S. J. Caffeine kunye namandla e-anticonvulsant amachiza e-antiepileptic: idatha yovavanyo kunye neklinikhi. IPhemacol. Ngo-2011; 63: 12-18. Jonga i-abstract.
  64. ILuszczki, J., Zuchora, M., Sawicka, K. M., Kozinska, J., kunye noCzuczwar, S. J. Ukuvezwa ngokukuko kwi-caffeine kunciphisa isenzo se-anticonvulsant se-ethosuximide, kodwa hayi eyokuxhamla kwe-clonazepam, phenobarbital kunye ne-valproate ngokuchasene ne-pentetrazole-induction seiz. IPhemacol Rep. 2006; 58: 652-659. Jonga i-abstract.
  65. UJankiewicz, K., Chroscinska-Krawczyk, M., Blaszczyk, B., kunye noCzuczwar, S. J. [Caffeine kunye neziyobisi ezichasene ne-antiepileptic: idatha yovavanyo kunye neklinikhi]. Przegl.Ilek. Ngo-2007; 64: 965-967. Jonga i-abstract.
  66. UGasior, M., Borowicz, K., Buszewicz, G., Kleinrok, Z., kunye noCzuczwar, S. J. Umsebenzi weAnticonvulsant we-phenobarbital kunye ne-valproate ngokuchasene ne-electroshock ephezulu kwiimpuku ngexesha lonyango olungapheliyo kunye ne-caffeine kunye ne-caffeine yokuyeka. Isifo sokuwa 1996; 37: 262-268. Jonga i-abstract.
  67. UFuhr, U., Strobl, G., Manaut, F., Anders, EM, Sorgel, F., Lopez-de-Brinas, E., Chu, DT, Pernet, AG, Mahr, G., Sanz, F. , kunye. I-Quinolone antibacterial agents: ubudlelwane phakathi kolwakhiwo kunye ne-in vitro inhibition yecytochrome yomntu P450 isoform CYP1A2. Umol. IPharmacol. Ngo-1993; 43: 191-199. Jonga i-abstract.
  68. I-Stille, W., Harder, S., Mieke, S., Beer, C., Shah, P. M., Frech, K., kunye neStaib, A. H. Ukuncitshiswa kokupheliswa kwe-caffeine emntwini ngexesha lokulawulwa kwe-4-quinolones. J. Izixhobo zokulwa. Ngo-1987; 20: 729-734. Jonga i-abstract.
  69. Staib, A.H, Stille, W., Dietlein, G., Shah, P.M, Harder, S., Mieke, S., kunye neBeer, C.Ukusebenzisana phakathi kwequinolones kunye necaffeine. Iziyobisi 1987; 34 Suppl 1: 170-174. Jonga i-abstract.
  70. IKynast-Gales SA, iMassey LK. Iziphumo zecaffeine kwi-circadian excretion ye-urinary calcium kunye ne-magnesium. J NdinguColl Nutraki. Ngo-1994; 13: 467-72. Jonga i-abstract.
  71. Irwin PL, King G, Hicks KB. I-Polymerized cyclomaltoheptaose (i-beta-cyclodextrin, i-beta-CDn) yokubandakanya ukubumba okuntsonkothileyo kunye ne-chlorogenic acid: iziphumo zesisombululo kwi-thermochemistry kunye ne-enthalpy-entropy mbuyekezo ICarbohydr Res. Ngo-1996 uFebruwari 28; 282: 65-79. Jonga i-abstract.
  72. Irwin PL, Pfeffer PE, Doner LW, okqhubekayo. Ukubopha ijiyometri, i-stoichiometry, kunye ne-thermodynamics ye-cyclomalto-oligosaccharide (cyclodextrin) yokubandakanya ukubumba okuntsonkothileyo kunye ne-chlorogenic acid, eyona ndawo iphambili yeapile polyphenol oxidase. ICarbohydr Res. Ngo-1994 ngoMatshi 18; 256: 13-27. Jonga i-abstract.
  73. UMoreira DP, uMonteiro MC, uRibeiro-Alves M, et al. Igalelo lee-asidi ze-chlorogenic kwimisebenzi yokunciphisa isinyithi kotywala. J Agric Ukutya Chem. 2005 uMatshi 9; 53: 1399-402. Jonga i-abstract.
  74. Ukuxhathisa iRF, uReddy M, uCook JD. Ukuthintela ukufunxwa kwentsimbi engeyi-haem emntwini ngeziyobisi ezine-polyphenolic. Br J Amayeza 1999; 81: 289-95. Jonga i-abstract.
  75. van Rooij J, van der Stegen GH, Schoemaker RC, okqhubekayo. Uphononongo olufanayo olulawulwa yi-placebo lweziphumo zeentlobo ezimbini zeoyile yekofu kwi-serum lipids kunye ne-transaminases: Ukuchongwa kwezinto ezinekhemikhali ezibandakanyekayo kwiziphumo zokunyusa ikofu. NdinguJ oNyango lweeKlinikhi. Ngo-1995 uJun; 61: 1277-83. Jonga i-abstract.
  76. -Jackson, L. S. kunye no-Lee, K. Iifom zekhemikhali zentsimbi, i-calcium, i-magnesium kunye ne-zinc kwikofu kunye nokutya kweempuku eziqukethe ikofu. J-Food-Prot. Ames, Iowa: Umbutho wamanye amazwe wobisi, ukutya, kunye neZendalo zeSanitarians ngo-1988; 51: 883-886.
  77. IPereira MA, iParker ED, kunye neFolsom AR. Ukusetyenziswa kwekofu kunye nomngcipheko wohlobo lwe-2 yesifo seswekile: isifundo seminyaka eli-11 esinokufundwa kwabasetyhini abayi-28 812 abasele besemaphepheni. IArch Intern Med. Ngo-2006 uJuni 26; 166: 1311-6. Jonga i-abstract.
  78. UJohnston KL, uClifford MN, uMorgan LM. Ikofu iguqula ngokufihlakeleyo isisu sehomoni kunye nokunyamezelana kweswekile ebantwini: iziphumo ze-glycemic ye-chlorogenic acid kunye ne-caffeine. NdinguJ oNyango lweeKlinikhi. Ngo-2003 u-Okthobha; 78: 728-33. Jonga i-abstract.
  79. I-Keijzers GB, iDe Galan BE, iTack CJ, et al. I-caffeine inokunciphisa ubuntununtunu kwi-insulin ebantwini. Unonophelo lweSwekile. NgoFebruwari 2002; 25: 364-9. Jonga i-abstract.
  80. UGreer F, uHudson R, uRoss R, et al. Ukungenisa kweCaffeine kunciphisa ukulahlwa kweglucose ngexesha le-hyperinsulinemic-euglycemic clamp kubantu abahleliyo. Seswekile. 2001 Okt; 50: 2349-54. Jonga i-abstract.
  81. Thong FS kunye noGraham TE. Ukukhubazeka okubangelwa yiCaffeine yonyamezelo lweswekile kuyapheliswa yi-beta-adrenergic receptor blockade ebantwini. J Appl Physiol. Ngo-2002 uJuni; 92: 2347-52. Jonga i-abstract.
  82. USuzuki A, uKagawa D, uOchiai R, et al. Ukukhutshelwa kwembotyi yekofu eluhlaza kunye nemetabolites yayo inefuthe lokungakhathali kwiigundane ezixinzelelekileyo. IiHypertens Res. Ngo-2002 uJan; 25: 99-107. Jonga i-abstract.
  83. I-Blum J, i-Lemaire B, kunye ne-Lafay S. Iziphumo zokukhupha ikofu eluhlaza eluhlaza ekhutshwe kwi-glycaemia: isifundo esiza kuba ngumqhubi wenqwelomoya. IiNutrafoods 2007; 6: 13-17.
  84. IYamaguchi T, iChikama A, uMori K, et al. Ikofu yasimahla ye-Hydroxyhydroquinone: isifundo esingafakwanga solawulo lwempendulo yedosi yoxinzelelo lwegazi. Isondlo Metab Cardiovasc Dis. U-2008 uJulayi; 18: 408-14. Jonga i-abstract.
  85. U-Olthol MR, u-Hollman PCH, uKatan MB. I-Chlorogenic acid kunye ne-caffeic acid ziyangena ebantwini. J Amanqatha 2001; 131: 66-71. Jonga i-abstract.
  86. IVinson JA, iBurnham BR, iNagendran MV. I-Randomised, blind-blind, elawulwa yi-placebo, idosi yomgama, isifundo se-crossover sokuvavanya ukusebenza kakuhle kunye nokhuseleko lokukhutshwa kwembotyi yekofu eluhlaza kwizifundo ezingaphezulu komzimba. Isifo seswekile iMetab Syndr Obes 2012; 5: 21-7. Jonga i-abstract.
  87. UDellalibera O, uLemaire B, uLafay S. Svetol, ukukhutshwa kwekofu eluhlaza, kunciphisa ukwehla kwesisindo kunye nokunyusa ukutyeba kumyinge wobunzima bamafutha kumavolontiya anengxaki yokutya kakhulu. UPhytotherapie 2006; 4: 194-7.
  88. Thom E. Iziphumo ze-chlorogenic acid ityebise ikofu ekufunxeni iswekile kumavolontiya asempilweni kunye nefuthe layo kubunzima bomzimba xa isetyenziswa ixesha elide kubantu abatyebe kakhulu nabatyebe kakhulu. J Int Med Res 2007; 35: 900-8. Jonga i-abstract.
  89. U-Onakpoya I, uTerry R, ​​u-Ernst E. Ukusetyenziswa kokukhutshwa kwekofu eluhlaza njengokuncedisa ukunciphisa umzimba: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta zezilingo zeklinikhi. Ukusebenza kweGastroenterol Res 2011; 2011. pii: 382852. Epub 2010 Aug 31. Jonga i-abstract.
  90. I-Alonso-Salces RM, Serra F, Reniero F, Héberger K. Botanical kunye neempawu zobume bekhofi eluhlaza (I-Coffea arabica kunye neCoffea canephora): uvavanyo lwe-chemometric lwe-phenolic kunye ne-methylxanthine. J Agric Ukutya Chem 2009; 57: 4224-35. Jonga i-abstract.
  91. I-Shimoda H, Seki E, Aitani M.Impembelelo yokuthotywa kwembotyi yekofu eluhlaza ekuqokeleleni amafutha kunye nokuzuza ubunzima bomzimba kwiimpuku. I-BMC yokuGqibezela enye iMed 2006; 6: 9. Jonga i-abstract.
  92. UFarah A, uDonangelo CM. Iikhompawundi phenolic ikofu. IBraz J yokuTyala kwePhysiol 2006; 18: 23-36.
  93. UFarah A, Monteiro M, uDonangelo CM, uLafay S.Iichlorogenic acid ezivela kwisicatshulwa sekhofi eluhlaza zifumaneka kakhulu ebantwini. J Utyando 2008; 138: 2309-15. Jonga i-abstract.
  94. UWatanabe T, uArai Y, uMitsui Y, et al. Impembelelo yokwehlisa uxinzelelo lwegazi kunye nokhuseleko lwe-chlorogenic acid evela kwibhontshisi eluhlaza yekofu ekhutshwe kuxinzelelo lwegazi. Iiklinikhi Exp Hypertens 2006; 28: 439-49. Jonga i-abstract.
  95. UKozuma K, uTsuchiya S, uKohori J, et al. Isiphumo sokuxinzelela uxinzelelo lweembotyi zekofu eluhlaza kwizifundo ezinobushushu obuphezulu. IiHypertens Res. 2005 Sep; 28: 711-8. Jonga i-abstract.
  96. UOchiai R, uJokura H, uSuzuki A, et al. Ukukhutshelwa kwembotyi yekofu eluhlaza kuphucula ukungasebenzi kakuhle komntu. IiHypertens Res 2004; 27: 731-7. Jonga i-abstract.
  97. UDuncan L. Imbotyi yekofu eluhlaza etshisa amanqatha ngokukhawuleza. Umboniso kaGqirha Oz, Epreli 25, 2012. Iyafumaneka apha: http://www.doctoroz.com/blog/lindsey-duncan-nd-cn/green-coffee-bean-burns-fat-fast.
  98. ILake CR, iRosenberg DB, iGallant S, et al. I-Phenylpropanolamine inyusa amanqanaba e-plasma caffeine. KwiKlinikhi ye-Pharmacol Ther 1990; 47: 675-85. Jonga i-abstract.
  99. I-Forrest WH Jr, iBellville JW, uBrown BW Jr.Ukusebenzisana kwe-caffeine kunye ne-pentobarbital njenge-hypnotic yasebusuku. I-Anesthesiology 1972; 36: 37-41. Jonga i-abstract.
  100. URaaska K, uRaitasuo V, uLaitila J, uNeuvonen PJ. Iziphumo zecaffeine equlathe ikofu enganyibilikiweyo kwindawo ekugxininiswe kuyo i-serum clozapine kwizigulana ezibhedlele. Isiseko seKlinikhi yePhemacol Toxicol 2004; 94: 13-8. Jonga i-abstract.
  101. UWatson JM, uSherwin RS, uDeary IJ, et al. Ukwahlulahlulahlulwa komzimba okwandisiweyo, iimpendulo zehomoni kunye nokuqonda kwi-hypoglycaemia ngokusetyenziswa kwecaffeine okuzinzileyo. Iiklinikhi yeSci (uLond) 2003; 104: 447-54. Jonga i-abstract.
  102. IWinkelmayer WC, iStampfer MJ, iWillett WC, iCurhan GC. Ukutya okuqhelekileyo kwe-caffeine kunye nomngcipheko wexinzelelo lwexinzelelo kubafazi. IJAMA 2005; 294: 2330-5. Jonga i-abstract.
  103. UJuliano LM, noGriffiths RR. Uphengululo olubalulekileyo lokurhoxiswa kwecaffeine: ubungqina bokuqina kweempawu kunye neempawu, izehlo, ubungqongqo, kunye neempawu ezinxulumene noko. Ingqondo yePsychopharmacology (Berl) 2004; 176: 1-29. Jonga i-abstract.
  104. UAnderson BJ, uGunn TR, uHolford NH, uJohnson R. Caffeine overdose kwimveku engaphambi kwexesha: ikhosi yeklinikhi kunye ne-pharmacokinetics. Unonophelo olunzulu lweAnaesth 1999; 27: 307-11. Jonga i-abstract.
  105. I-Leson CL, McGuigan MA, iBryson SM. I-caffeine overdose kwindoda efikisayo. J Ityhefu yeklinikhi yetyhefu 1988; 26: 407-15. Jonga i-abstract.
  106. UBenowitz NL, u-Osterloh J, uGoldschlager N, et al. Ukukhutshwa kwe-catecholamine enkulu kwi-caffeine yetyhefu. IJAMA 1982; 248: 1097-8. Jonga i-abstract.
  107. IHallerle CA, uBenowitz NL, uJacob P 3rd. Iziphumo zeHemodynamic ze-ephedra-free-weight loss-supplements ebantwini. NdinguJ Med 2005; 118: 998-1003 .. Jonga i-abstract.
  108. UPetrie HJ, uChown SE, uBelfie LM, et al. Ukungenisa kweCaffeine kwandisa impendulo ye-insulin kuvavanyo lomlomo-lweswekile-ukunyamezeleka kumadoda atyebileyo ngaphambi nasemva kokuphulukana nobunzima. NdinguJ J Clin Nutriti 2004; 80: 22-8. Jonga i-abstract.
  109. Umgaqo JD, Barkauskas CE, Surwit RS, Feinglos MN. I-caffeine yonakalisa imetabolism yohlobo lwe-2 lweswekile. Unonophelo lweSwekile 2004; 27: 2047-8. Jonga i-abstract.
  110. Ixesha elide KL. Imithombo eyaziwayo nefihliweyo ye-caffeine kwiziyobisi, ekutyeni nakwimveliso yendalo. J Ndingu-Pharm Assoc 2002; 42: 625-37. Jonga i-abstract.
  111. Ulwandle CA, Mays DC, Guiler RC, et al. Ukuthintela ukupheliswa kwe-caffeine yi-disulfiram kwizifundo eziqhelekileyo kunye nokubuyisa iziyobisi. Kwiklinikhi ye-Pharmacol Ther 1986; 39: 265-70. Jonga i-abstract.
  112. IDews PB, O'Brien CP, Bergman J. Caffeine: Iziphumo zokuziphatha zokurhoxa kunye nemicimbi ehambelana nayo. Ukutya iChem Toxicol 2002; 40: 1257-61. Jonga i-abstract.
  113. IHolmgren P, i-Norden-Pettersson L, i-Ahlner J. Caffeine yokusweleka-iingxelo zamatyala amane. I-Forensic Sci Int 2004; 139: 71-3. Jonga i-abstract.
  114. Iziko lezeMpilo. I-Caffeine yoLondolozo lweNtsebenzo yeNgqondo yokuSebenza: Iifom zokuSebenza koMkhosi. IWashington, DC: I-National Academy Press, 2001. Iyafumaneka apha: http://books.nap.edu/books/0309082587/html/index.html.
  115. UZheng XM, uWilliam RC. Amanqanaba e-caffeine ye-serum emva kokungabikho kweyure ye-24: iimpembelelo zeklinikhi kwi-dipyridamole Tl ye-myocardial imaging perfusion. J Nucl Med Technol 2002; 30: 123-7. Jonga i-abstract.
  116. I-Aqel RA, iZoghbi GJ, iTrimm JR, et al. Iziphumo zecaffeine elawulwa ngaphakathi ngaphakathi ngaphakathi kwi-adenosine-eyanyanzeliswa yi-coronary hemodynamics kwizigulana ezinesifo semithambo. NdinguJ Cardiol 2004; 93: 343-6. Jonga i-abstract.
  117. Ngaphantsi kwe-DA. Ngawaphi amayeza ekufuneka abanjwe ngaphambi kovavanyo lwe-pharmacologic okanye lovavanyo lokuzivocavoca? Iklinikhi yokuCoca uJ Med 2002; 69: 449-50. Jonga i-abstract.
  118. USmith A.Iziphumo zecaffeine ekuziphatheni komntu. Ukutya kweKhem Toxicol 2002; 40: 1243-55. Jonga i-abstract.
  119. UStanek EJ, uMelko GP, uCharland SL. Ukuphazamiseka kweXanthine nge-dipyridamole-thallium-201 imaging ye-myocardial. Unyango ngo-1995; 29: 425-7. Jonga i-abstract.
  120. UCarrillo JA, uBenitez J.Ukusebenzisana kweekhemikhali phakathi kwecafine yokutya kunye namayeza. Kwiiklinikhi zeFarmacokinet 2000; 39: 127-53. Jonga i-abstract.
  121. I-Wahllander A, Paumgartner G. Iziphumo ze-ketoconazole kunye ne-terbinafine kwi-pharmacokinetics ye-caffeine kumavolontiya asempilweni. I-Eur J Clin Pharmacol 1989; 37: 279-83. Jonga i-abstract.
  122. USanderink GJ, uBournique B, uStevens J, et al.Ukubandakanyeka kwe-CYP1A isoenzymes yomntu kwimetabolism kunye nokunxibelelana kweziyobisi kwe-riluzole in vitro. I-Pharmacol Exp Ther 1997; 282: 1465-72. Jonga i-abstract.
  123. I-Brown NJ, i-Ryder D, i-RA yesebe. Unxibelelwano lwe-pharmacodynamic phakathi kwe-caffeine kunye ne-phenylpropanolamine. KwiKlinikhi ye-Pharmacol Ther 1991; 50: 363-71. Jonga i-abstract.
  124. I-Abernethy DR, Todd EL. Ukuphazamiseka kwendlela yokucoca i-caffeine ngokusetyenziswa okungapheliyo kweedosi ezisezantsi ezine-contraceptive zomlomo. I-Eur J Clin Pharmacol 1985; 28: 425-8. Jonga i-abstract.
  125. NgoMeyi DC, uJarboe CH, uVanBakel AB, uWilliam WM. Iziphumo ze-cimetidine kwindawo ye-caffeine kubantu abatshayayo nakwabo bangatshayiyo. KwiKlinikhi ye-Pharmacol Ther 1982; 31: 656-61. Jonga i-abstract.
  126. UGertz BJ, Holland SD, Kline WF, et al. Izifundo zokufumaneka komlomo kwi-alendronate. Kwiklinikhi ye-Pharmacol Ther 1995; 58: 288-98. Jonga i-abstract.
  127. UNawrot P, iJordani S, i-Eastwood J, et al. Iziphumo zecaffeine kwimpilo yabantu. Ukongezwa kokutya kwiContam 2003; 20: 1-30. Jonga i-abstract.
  128. IMassey LK, iWhiting SJ. I-caffeine, i-calcium yokuchama, i-calcium metabolism kunye nethambo. J Amanqatha 1993; 123: 1611-4. Jonga i-abstract.
  129. I-Infante S, iBaeza ML, iCalvo M, okqhubekayo. I-Anaphylaxis ngenxa ye-caffeine. Ukunyuka komzimba ngo-2003; 58: 681-2. Jonga i-abstract.
  130. UNix D, uZelenitsky S, uSymonds W, et al. Iziphumo zefluconazole kwi-pharmacokinetics ye-caffeine kwizifundo ezincinci nezindala. Kwiklinikhi ye-Pharmacol Ther 1992; 51: 183.
  131. IKockler DR, uMcCarthy MW, uLawson CL. Umsebenzi wokubamba kunye nokungaphenduli emva kokungenisa i-hydroxycut. I-Pharmacotherapy 2001; 21: 647-51 .. Jonga i-abstract.
  132. IMassey LK. Ngaba icaffeine ingumngcipheko wokulahleka kwethambo kubantu abadala? NdinguJ J Clin Nutr 2001; 74: 569-70. Jonga i-abstract.
  133. IBara AI, iBarley EA. Caffeine yesifuba. Isiseko sedatha yeCochrane Syst Rev 2001; 4: CD001112 .. Jonga i-abstract.
  134. IPorner NK, iLampe JW. Iindlela ezinokubakho zonyango lokutya kwiimeko zebele le-fibrocystic zibonisa ubungqina obungonelanga bokusebenza. J Nditya i-Assoc 2000; 100: 1368-80. Jonga i-abstract.
  135. I-Bell DG, i-Jacobs I, i-Ellerington K. Iziphumo ze-caffeine kunye ne-ephedrine yokungenisa ukusebenza kwe-anaerobic. Ukuzivocavoca kweMed Sci Exerc 2001; 33: 1399-403. Jonga i-abstract.
  136. I-Avisar R, i-Avisar E, i-Weinberger D. Iziphumo zokusetyenziswa kwekofu kuxinzelelo lwe-intraocular. UAnn Pharmacother 2002; 36: 992-5 .. Jonga i-abstract.
  137. UFerrini RL, uBarrett-Connor E.Icaffeine yokutya kunye nenqanaba lesini le-steroid elingapheliyo kubafazi be-postmenopausal. Isifundo seRancho Bernardo. NdinguJ Epidemiol 1996: 144: 642-4. Jonga i-abstract.
  138. Olthof MR, Hollman PC, Zock PL, Katan MB. Ukusetyenziswa kweedosi eziphezulu ze-chlorogenic acid, ekhoyo kwikofu, okanye iti emnyama yonyusa inani leplasma ye-homocysteine ​​ebantwini. NdinguJ J Clin Nutr 2001; 73: 532-8. Jonga i-abstract.
  139. UKlag MJ, uWang NY, uMeoni LA, et al. Ukutya ikofu kunye nomngcipheko wexinzelelo lwegazi: Isifundo sokuqala sikaJohn Hopkins. IArch Intern Med 2002; 162: 657-62. Jonga i-abstract.
  140. I-Samarrae WA, iTruswell AS. Iziphumo zexesha elifutshane zekofu kwimisebenzi yegazi ye-fibrinolytic kubantu abadala abasempilweni. I-Atherosclerosis 1977; 26: 255-60. Jonga i-abstract.
  141. UArdlie NG, uGlew G, uSchultz BG, uSchwartz CJ. Inhibition kunye nokubuyiselwa umva kweplatelet aggregation yi-methyl xanthines. UTromb Diath Haemorrh 1967; 18: 670-3. Jonga i-abstract.
  142. UAli M, Afzal M. Isithinteli esinamandla se-thrombin evuselelekileyo yeplatelet thromboxane ekwakhiweni kweti engagqitywanga. Iprostaglandins Leukot Med 1987; 27: 9-13. Jonga i-abstract.
  143. IHallerle CA, iBenowitz NL. Iziganeko zenkqubo ye-cardiovascular and central system ehambelana nezongezelelo zokutya eziqukethe i-ephedra alkaloids. N Engl J Med 2000; 343: 1833-8. Jonga i-abstract.
  144. USinclair CJ, uGiiger JD. Ukusetyenziswa kweCaffeine kwezemidlalo. Uphengululo lwekhemesti. J Ezemidlalo ngokuDinwa komzimba 2000; 40: 71-9. Jonga i-abstract.
  145. ULloyd T, uJohnson-Rollings N, uEggli DF, et al. Ubume bethambo phakathi kwabafazi abasemva kwemiphefumlo abanendlela eyahlukeneyo yokuthatha ikhaffeine: uphando olude. J Ndingu-Coll Nutrut 2000; 19: 256-61. Jonga i-abstract.
  146. UWatson JM, uJenkins EJ, uHamilton P, et al. Impembelelo ye-caffeine kwisantya kunye nokuqonda kwe-hypoglycemia kwizigulana ezihlala simahla ezine-1 yeswekile. Unonophelo lweSwekile 2000; 23: 455-9. Jonga i-abstract.
  147. IHagg S, Spigset O, Mjorndal T, Dahlqvist R. Iziphumo zecaffeine kwi-clozapine pharmacokinetics kumavolontiya asempilweni. UBr J Clin Pharmacol 2000; 49: 59-63. Jonga i-abstract.
  148. UBozer CN, uNasser JA, uHeymsfield SB, et al. Isongezelelo semifuno esineMa Huang-Guarana yokunciphisa umzimba: ityala elingenamsebenzi, elingaboni kabini. I-Int J Obes edibanisa iMetab Disord 2001; 25: 316-24. Jonga i-abstract.
  149. UDews PB, uC Curtis GL, uHanford KJ, u-O'Brien CP. Ukuphindaphindeka kokurhoxiswa kwe-caffeine kuvavanyo olusekwe kubemi nakwilingo elilawulwayo, elingaboniyo. J Clin Pharmacol 1999; 39: 1221-32. Jonga i-abstract.
  150. INurminen ML, Niittynen L, Korpela R, Vapaatalo H. Ikofu, icaffeine kunye noxinzelelo lwegazi: uphononongo olunzulu. I-Eur J yeKlinikhi yeNutrig 1999; 53: 831-9. Jonga i-abstract.
  151. IPollock BG, uWylie M, uStack JA, et al. Ukuthintela i-caffeine metabolism ngonyango lwe-estrogen endaweni yabasetyhini abasemva kwemasopaopausal. J Clin Pharmacol 1999; 39: 936-40. Jonga i-abstract.
  152. URapuri PB, uGallagher JC, uKinyamu HK, uRyschon KL. Ukutya kweCaffeine kunyusa inqanaba lokulahleka kwethambo kubafazi abadala kwaye kunxibelelana ne-vitamin D receptor genotypes. NdinguJ J Clin Nutr 2001; 74: 694-700. Jonga i-abstract.
  153. UChiu KM. Ukusebenza kwe-calcium yongeza kwisithambo kubasetyhini abase-postmenopausal. J Gerontol A Biol Sci Med Sci 1999; 54: M275-80. Jonga i-abstract.
  154. Ukutolikwa koVavanyo lovavanyo. Isishwankathelo seLebhu yelebhu. Eyesihlanu ed; IBoston, MA: Encinci kaBrown, ngo-1992.
  155. IHodgson JM, iPuddey IB, uBurke V, et al. Iziphumo kuxinzelelo lwegazi lokusela iti eluhlaza kunye emnyama. J Hypertens 1999; 17: 457-63 (PubMed) (Umnqamlezo) Jonga i-abstract.
  156. Wakabayashi K, Kono S, Shinchi K, okqhubekayo. Ukusetyenziswa kwesiqhelo kwekofu kunye noxinzelelo lwegazi: Uphononongo lwamagosa okuzikhusela eJapan. I-Eur J Epidemiol 1998; 14: 669-73. Jonga i-abstract.
  157. UVahedi K, uDomingo V, uAmarenco P, uBousser MG. Ischemic stroke kwimbaleki esebenzise i-MaHuang isicatshulwa kunye nokudala i-monohydrate yokwakha umzimba. J Neurolurosuroski yengqondo 2000; 68: 112-3. Jonga i-abstract.
  158. UJoeres R, uKlinker H, uHeusler H, et al. Impembelelo ye-mexiletine ekupheliseni i-caffeine. IPhemacol Ther 1987; 33: 163-9. Jonga i-abstract.
  159. UJefferson JW. Ukungcangcazela kweLithium kunye nokutya kwe-caffeine: iimeko ezimbini zokusela kancinci kunye nokugungqa ngakumbi. J Iklinikhi yengqondo 1988; 49: 72-3. Jonga i-abstract.
  160. UMester R, uToren P, uMizrachi I, et al. Ukurhoxiswa kweCaffeine kwonyusa amanqanaba egazi e-lithium. I-Biol Psychiatry 1995; 37: 348-50 (PubMed) (Umnqamlezo) Jonga i-abstract.
  161. IHealy DP, iPolk RE, iKanawati L, et al. Ukusebenzisana phakathi komlomo we-ciprofloxacin kunye ne-caffeine kumavolontiya aqhelekileyo. Iiarhente zeAntimicrob Chemother 1989; 33: 474-8. Jonga i-abstract.
  162. UCarbo M, uSegura J, uDe la Torre R, okqhubekayo. Iziphumo zequinolones ekubekweni kwe-caffeine. KwiKlinikhi ye-Pharmacol Ther 1989; 45: 234-40. Jonga i-abstract.
  163. I-Harder S, i-Fuhr U, i-Staib AH, i-Wolff T.I-Ciprofloxacin-caffeine: Unxibelelwano lweziyobisi olusekwe kusetyenziswa i-vivo kunye nophando lwe-vitro. NdinguJ Med 1989; 87: 89S-91S. Jonga i-abstract.
  164. UMcEvoy GK, ed. Ulwazi lwe-AHFS yeziyobisi. I-Bethesda, MD: Umbutho waseMelika we-Health-System Pharmacists, 1998.
Ukuhlaziywa okokugqibela-03/01/2021

Olona Kufundo Lukhulu

Izinto ezi-5 ezimisela uhlobo lwebele
Indlela Yokuphila

Izinto ezi-5 ezimisela uhlobo lwebele

Ube kumagumbi okut hixa ngokwaneleyo ukuba wazi ukuba amabele wonke umfazi khangela ezahlukeneyo. “Phant e akukho mntu unamabele alinganayo ngokugqibeleleyo,” ut hilo uMary Jane Minkin, MD, unjingalwa...
Xa Ukuya kwi-Commando yinto elungileyo
Indlela Yokuphila

Xa Ukuya kwi-Commando yinto elungileyo

Iingcali zeGynecologi t zihlala zincoma ukukhupha iipantie zakho ngelixa ulele, njengendlela yokuvumela i-vulva yakho iphefumle (kwaye inokunciphi a umngcipheko wo ulelo). Nangona kunjalo yi-18 yeepe ...